Dotz Nano Limited announced that Mr. Sharon Malka has been appointed Chief Executive Officer of the Company, effective immediately. Mr. Malka's appointment follows an extensive international recruitment process led by Dotz's Board of Directors. With the appointment of Mr. Malka, Dotz Executive Chairman Mr. Bernie Brookes AM will resume the role of Independent Non-Executive Chairman. Mr. Malka is an accomplished senior executive with over 20 years of strategic, operational, commercial and financial leadership in innovative technology companies. His international experience working for a range of organizations includes US listed companies and a track record in raising capital, mergers and acquisitions, building and managing high performance teams, developing technical assets and driving corporate growth. Prior to joining Dotz, Mr. Malka served as Chief Executive Officer of MediWound Ltd. During his time at MediWound, he directed the development of an
innovative drug through world-wide regulatory approvals and led its global commercialization strategy via multiple distribution channels and collaborations, becoming the new standard-of-care. In addition, he established a certified pharmaceutical manufacturing capacity to support a global commercial launch. In doing so acquired an intimate understanding of technology development roadmaps and commercialisation pathways. Prior to that, Mr. Malka was a partner at Variance Economic Consulting Ltd., a multi-disciplinary consulting boutique, specialising in financial services for international and local Hi-Tech clients. Mr. Malka also served as a Senior Manager at PricewaterhouseCoopers Corporate Finance, where he gained extensive experience in company valuations, joint ventures and financial instruments for investments, M&A, and IPOs. Mr. Malka is a certified CPA and holds a B.Sc. in Business Administration from the Business Management College in Israel and an M.B.A. from Bar Ilan University, Israel.